808738-20-7

Basic information

• Product Name: 2-(5-Cyclopropylcarbamoyl-2-methyl-phenylamino)-4-(4-fluoro-3-methyl-phenyl)-thiazole-5-carboxylic acid benzylamide
• Synonyms: 2-(5-Cyclopropylcarbamoyl-2-methyl-phenylamino)-4-(4-fluoro-3-methyl-phenyl)-thiazole-5-carboxylic acid benzylamide
• CAS NO: 808738-20-7
• Molecular Weight: 514.623
• Mol File: 808738-20-7.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: 2-(5-Cyclopropylcarbamoyl-2-methyl-phenylamino)-4-(4-fluoro-3-methyl-phenyl)-thiazole-5-carboxylic acid benzylamide(CAS DataBase Reference)
• NIST Chemistry Reference: 2-(5-Cyclopropylcarbamoyl-2-methyl-phenylamino)-4-(4-fluoro-3-methyl-phenyl)-thiazole-5-carboxylic acid benzylamide(808738-20-7)
• EPA Substance Registry System: 2-(5-Cyclopropylcarbamoyl-2-methyl-phenylamino)-4-(4-fluoro-3-methyl-phenyl)-thiazole-5-carboxylic acid benzylamide(808738-20-7)

Safety Data

• Hazardous Substances Data: 808738-20-7(Hazardous Substances Data)

Upstream product

• 808738-19-4 4-bromo-2-(5-cyclopropylcarbamoyl-2-methyl-phenylamino)-thiazole-5-carboxylic acid benzylamide 
• 584-08-7 potassium carbonate 
• 139911-27-6 4-fluoro-3-methylphenyl boronic acid 

Relevant articles and documents

P-38 inhibitors

Provided are 5-membered heterocycle-based p38 kinase, including p38α and p38β kinase, inhibitors. Pharmaceutical compositions containing the compounds are also provided. Methods of use of the compounds and compositions are also provided, including methods of treatment, prevention, or amelioration of one or more symptoms of p38 kinase mediated diseases and disorders, including, but not limited to, inflammatory diseases and disorders.